Age and the treatment gap in the use of statins

Lancet

Volumn 361, Issue 9373, 2003, Pages 1925-1926

  Chin Dusting, Jaye P F ^a   Dart, Anthony M ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; STATIN;

AGE DETERMINATION; AUSTRALIA; CHOLESTEROL BLOOD LEVEL; GENERAL PRACTITIONER; GERIATRICS; HUMAN; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; MEDICAL RECORD; MORTALITY; NOTE; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT PLANNING; UNITED KINGDOM; UNITED STATES;

EID: 0038543210     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13601-X     Document Type: Note

References (14)

1. National Service Framework on Coronary Heart Disease - emerging findings report. London: Department of Health, 1998: http://www.doh.gov.uk/pub/docs/doh/coronary.pdf (accessed May 15, 2003).
2. DeWilde S., Carey I.M., Bremner S.A., Richards N., Hilton S.R., Cook D.G. Evolution of statin prescribing 1994-2001: a case of agism but not sexism? Heart. 89:2003;417-421.
3. Bowker T.J., Clayton T.C., Ingham J., et al. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention Reduce Events). Heart. 75:1996;334-342.
4. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eu Heart J 1997; 18: 394-413.
5. Reducing risk in heart disease. Guidelines for preventing cardiovascular events in people with coronary heart disease. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand, 2003. http://www.heartfoundation.com.au/prof/index_fr.html (accessed May 30, 2003).
6. American Heart Association. Cholesterol lowering drugs. 2003: http://www.americanheart.org/presenter.jhtml?identifier=557 (accessed May 15, 2003).
7. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360:2002;7-22.
8. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389.
9. Jackevicius C.A., Mamdani M., Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 288:2002;462-467.
10. Weverling-Rijnsburger A.W., Blauw G.J., Lagaay A.M., Knnok D.L., Meinders A.E., Westendorp R.G. Total cholesterol and risk of mortality in the oldest old. Lancet. 350:1997;119-123.
11. Bartlett C., Davey P., Dieppe P., Doyal L., Ebrahim S., Egger M. Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins in 1990 to 2001. Heart. 89:2003;327-328.
12. Shepherd J., Blauw G.J., Murphy M.B. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised trial. Lancet. 360:2002;1623-1630.
13. Vale MJ, Jelinek MV, Best JD, et al. Coaching patients on achieving cardiovascular health (COACH): a multicenter randomised trial in patients with coronary heart disease. Arch Intern Med (in press).
14. Hilleman D.E., Monaghan M.S., Ashby C.L., Mashni J.E., Woolley K., Amato C.M. Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease. Pharmacotherapy. 21:2001;1415-1421.